Management of prolactinomas. A reappraisal.
D000236:Adenoma / Q000188:drug therapy / Q000601:surgery; D001971:Bromocriptine / Q000008:administration & dosage; D004873:Ergolines / Q000008:administration & dosage; D005260:Female; D006801:Humans; D008090:Lisuride / Q000008:administration & dosage; D008711:Metergoline / Q000008:administration & dosage; D010479:Pergolide; D010911:Pituitary Neoplasms / Q000378:metabolism* / Q000601:surgery / Q000628:therapy; D011247:Pregnancy; D011388:Prolactin / Q000097:blood / Q000378:metabolism*; D011879:Radiotherapy Dosage; D011882:Radiotherapy, High-Energy; D013997:Time Factors
D004873:Ergolines; D008711:Metergoline; D010479:Pergolide; D001971:Bromocriptine; D011388:Prolactin; D008090:Lisuride; C031649:mesulergine